◀ Back to PTGS2
APOB — PTGS2
Text-mined interactions from Literome
Pontsler et al., J Biol Chem 2002
:
These cells express cyclooxygenase-2, but the way oxidized
LDL stimulates
cyclooxygenase-2 transcription is unknown
Norata et al., Int J Mol Med 2004
:
N-LDL and Ox-LDL
induced Cox-2 expression in a time- and dose dependent manner ... N-LDL and Ox-LDL increased PGE2 release in a
Cox-2 dependent manner while TXA2 and PGI2 release were not affected either by
n-LDL or Ox-LDL ... The finding that
n-LDL and Ox-LDL
induces Cox-2 in human endothelial cells through a p38 MAPK, NF-kappaB, CREB dependent pathway thus modulating PGE2 release, suggests a new mechanism by which these lipoproteins induce endothelial dysfunction, sustaining inflammatory processes in the arterial wall
Kanayama et al., J Biol Chem 2007
:
In the present study, based on the finding that HNE induced COX-2 expression only in the serum containing media, we characterized a serum component essential for the HNE induced COX-2 induction and found that
low density lipoprotein (LDL) that had been denatured by freeze thawing or oxidized LDL might be
involved in the
COX-2 induction
Taketa et al., J Biol Chem 2008
(Atherosclerosis...) :
Ox-LDL transiently induced cyclooxygenase-2 (COX-2) mRNA and protein expression, and COX-2 specific inhibition by NS-398 or meloxicam or small interference RNA of
COX-2 suppressed Ox-LDL induced PPARalpha and PPARgamma activation ... On the other hand,
Ox-LDL increased intracellular 15-deoxy-Delta ( 12,14 ) -prostaglandin J ( 2 ) ( 15d-PGJ ( 2 ) ) level through ERK1/2 dependent overexpression of
COX-2 ... Ox-LDL induced phosphorylation of ERK1/2 and p38 MAPK, and ERK1/2 specific inhibition abrogated
Ox-LDL induced
COX-2 expression and PPARalpha and PPARgamma activation, whereas p38 MAPK-specific inhibition had no effect
Zhao et al., J Cardiovasc Pharmacol 2008
:
The results showed that aspirin significantly suppressed
COX-2 and ICAM-1 expression
induced by
ox-LDL and also inhibited IkappaB phosphorylation in human umbilical vein endothelial cells ( HUVECs )